Graybug Vision announces pipeline expansion – Tips & Results

Graybug Vision Inc. today announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration (wet AMD), GB-401 in primary open-angle glaucoma (POAG), as well as its newly acquired assets in corneal disease (GB-501 ), inherited retinal disorders (GB-601), and geographic atrophy (GB-701). “We are very pleased to advance GB-102 into a … Read more

Glaucoma 360: Pandemic Resurrection: Glaucoma Drug Drop – Tips & Results

During the Glaucoma 360 New Horizons Forum, the spotlight was cast on innovations in glaucoma diagnosis and treatment—innovations that have thrived over the past year despite, or perhaps because of, an ongoing global pandemic. This portion of the forum showcased some of the technological advances in the field of drug and drug delivery, the latter … Read more